FTC Competition Hearings: PhRMA, Former Rep. Waxman Advocate Focus On PBMs
Executive Summary
FTC is assessing possible changes to competition and consumer protection enforcement law and policy, with a hearing on Innovation and IP Policy set for Oct. 23-24.